Mr. William Williams reports

BRIACELL ANNOUNCES AVAILABILITY OF ANNUAL GENERAL MEETING MATERIALS AND ALTERNATIVE VOTING PROCEDURES

Briacell Therapeutics Corp. will be relying on, and has satisfied all of the conditions to rely on, CSA Coordinated Blanket Order 51-931 for exemption from the requirements to send proxy-related materials for its upcoming annual general meeting, to be held on Thursday, Jan. 23, 2025, at Suite 3400, 1 First Canadian Place, Toronto, Ont., M5X 1A4, at 10 a.m. EST, due to the suspension of mail service in Canada from the nationwide strike of the Canadian Union of Postal Workers that commenced on Nov. 15, 2024.

The meeting materials have been posted under the company's profile on SEDAR+ and on the company's website. The meeting will address the following: receipt of audited financial statements and auditor's report; election of directors for the coming year; and appointment of the auditor and setting its remuneration.

The Canada Industrial Relations Board has ordered a return to work, but delays are expected due to the substantial backlog to be processed and delivered. The company will send the materials by regular mail; however, there is no assurance that the meeting materials will be received by the shareholders prior to the meeting. Shareholders of the company are encouraged to access the meeting materials directly through the above-mentioned websites. Shareholders are urged to vote before the proxy deadline of 10 a.m. EST on Tuesday, Jan. 21, 2025.

How registered shareholders can vote

Registered shareholders are shareholders who hold their shares directly in the company and not through a brokerage account or depository company. Registered shareholders can call Computershare Shareholder Services at 1-800-564-6253 (in Canada/the United States) or, for overseas holders, call direct dial number 1-514-982-7555 (Monday to Friday, 8:30 a.m. EST to 8 p.m. EST) to request their voting control numbers.

How beneficial shareholders can vote

Beneficial shareholders are shareholders who hold their investment through a brokerage house, depository company or other intermediary. There are two types of beneficial owners: (i) those who object to their identity being made known to the issuers of securities which they own (objecting beneficial owners or OBOs); and (ii) those who do not object to their identity being made known to the issuers of securities which they own (non-objecting beneficial owners or NOBOs).

The company has arranged to send meeting materials directly to NOBOs. NOBOs may submit their votes by completing the voting instruction form (VIF) available on the company's website and sending the completed VIF to Computershare by e-mail at service@computershare.com. NOBOs can also contact Computershare at 1-800-564-6253 to request their voting control numbers and instructions.

OBOs should contact their brokerage house or depository company or other intermediary, and ask to obtain their voting control number and instructions. Shareholders are strongly encouraged to vote via telephone (toll-free at 1-866-732-8683) or the Internet.

Completed and signed proxies and NOBO VIFs must be received by Computershare by 10 a.m. EST on Jan. 21, 2025.

Financial statements and MD&A (management's discussion and analysis)

The company's annual financial statements and related MD&A for the fiscal year ended July 31, 2024, as well as interim financial statements and related MD&A for the quarterly periods ended Oct. 31, 2023, Jan. 31, 2024, and April 30, 2024, have been filed and are available on the company's SEDAR+ profile and the company's website.

About Briacell Therapeutics Corp.

Briacell is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care.

We seek Safe Harbor.